Concomitant transcatheter aortic and mitral valve-in-valve replacements using transfemoral devices via the transapical approach: first case in United States.

From the Columbia University Medical Center/NewYork-Presbyterian Hospital and the Cardiovascular Research Foundation, New York, New York. Drs. Paradis, Kodali, Daneault, and Williams have received consulting fees from Edwards Lifesciences. Dr. Kodali is also a consultant for St. Jude Medical; he serves on the Scientific Advisory Board and has equity in Thubrikar Aortic Valve Inc. Dr. Hahn is a consultant for Abbott Vascular and the COAPT trial. Dr. Leon is a nonpaid member of the Scientific Advisory Board of Edwards Lifesciences and Medtronic Vascular; he is on the Executive Committee of the PARTNER trial. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Figure 1. TEE Showing the Mitral Bioprosthetic Valve